Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 26, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Coya Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 1
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Coya Therapeutics, Inc.
| 10K |
—
|
—
|
∞
| 10K |
Jan 3
| |||||||
Coya Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 20
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 9
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 19
| |||||||
Neubase Therapeutics, Inc.
| 8K |
$4.75 | $38,000.00 | +36.36% | 30K |
Jun 18
| |||||||
Neubase Therapeutics, Inc.
| 12K |
$5.00 | $60,000.00 | +120.00% | 22K |
Apr 26
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 9
| |||||||
Neubase Therapeutics, Inc.
| 10K |
$6.00 | $60,000.00 |
∞
| 10K |
Apr 30
| |||||||
Adma Biologics, Inc.
| 7.5K |
—
|
—
|
∞
| 7.5K |
Feb 28
| |||||||
Adma Biologics, Inc.
| 7.5K |
—
|
—
|
∞
| 7.5K |
Feb 28
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 12
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 13
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Esperion Therapeutics, Inc.
|
0
|
$16.47 | $214,100.00 |
—
| 47 |
Jun 6
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 23
| |||||||
Esperion Therapeutics, Inc.
|
0
|
$3.70 | $79,442.70 |
—
| 47 |
Dec 18
| |||||||
Esperion Therapeutics, Inc.
| 38 |
—
|
—
| +422.22% | 47 |
Dec 5
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 17
| |||||||
Esperion Therapeutics, Inc.
| -800.00K |
$41.66 | -$33,327,088.28 | -48.87% | 837.13K |
Mar 21 - Mar 22
| |||||||
Cempra, Inc.
| -150.00K |
$3.55 | -$533,115.84 | -100.00% |
0
|
Mar 7 - Mar 8
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
Cempra, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Cempra, Inc.
| -105.46K |
$3.40 | -$358,564.00 | -41.28% | 150K |
Jan 13
| |||||||
Cempra, Inc.
| -937.60K |
$3.41 | -$3,192,864.00 | -78.59% | 255.46K |
Jan 5 - Jan 6
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Cempra, Inc.
| -1.00M |
—
|
—
| -45.60% | 1.19M |
Mar 7
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 28
| |||||||
Cempra, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 1
| |||||||
Cempra, Inc.
|
0
|
$30.06 | -$25,314.48 |
—
| 50 |
Jun 22 - Jan 4
|
Scheduled
| ||||||
Cempra, Inc.
|
0
|
$35.74 | -$1,787,000.00 |
—
| 50 |
Jun 22
|
Scheduled
| ||||||
Cempra, Inc.
| -1.10M |
—
|
—
| -33.40% | 2.19M |
May 14
| |||||||
Esperion Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 14
| |||||||
Esperion Therapeutics, Inc.
| -199.99K |
—
|
—
| -10.89% | 1.64M |
Apr 28
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.